News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Pfizer Inc. (PFE)'s Breakthrough Vaccine Could Be A Victim Of Its Own Success


3/14/2014 8:30:35 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Yesterday morning at a conference on infectious disease in Hyderabad, India, Marc Bonten, an epidemiologist from Utrecht University, the Netherlands, presented results from a giant and innovative study Pfizer conducted of its vaccine, Prevnar 13, in adults over 65. In 84,496 Dutch patients over the age of 65, those who got a Prevnar 13 shot were 45.6% less likely to get serious pneumonia caused by the bacteria strains covered by Prevnar 13 than those who received a placebo shot. “Now, for the first time we know that a vaccine can prevent pneumonia in the elderly,” Bonten told me via phone.

Hey, check out all the research scientist jobs. Post your resume today!

Read at Forbes

comments powered by Disqus
Forbes
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES